梅州做处女膜的价格(梅州月经推迟几个月没来怎么办) (今日更新中)

WASHINGTON, June 6 (Xinhua) -- Women who have higher levels of the appetite-controlling hormone leptin have fewer symptoms of depression, and this apparent inverse relationship is not related to body mass index (BMI), a new study finds. The results were presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston, the United States."Animal data suggest that leptin may reduce anxiety and improve depression. Our study in women suggests that leptin may indeed have antidepressant qualities," said the study's lead author, Elizabeth Lawson, of Massachusetts General Hospital and Harvard Medical School in Boston.Leptin, the product of fat cells, signals satiety, or fullness. It is low in thin women and high in obese women, according to Lawson. She also said there is an increased prevalence of anxiety and depression in certain conditions in which leptin levels are typically low. These include the eating disorder anorexia nervosa, in which there is abnormally low weight and body fat, and functional hypothalamic amenorrhea, in which women have stopped menstruating despite having normal weight."It is unknown whether low leptin levels contribute to the development of mood disorders in these women," Lawson said.She and her co-workers studied the relationship between leptin levels and symptoms of anxiety and depression in 64 women. Fifteen of the women had anorexia nervosa, 12 were normal weight with hypothalamic amenorrhea, 20 were normal weight and in good health, and 17 were overweight or obese but still healthy.All subjects were asked questions to assess symptoms of depression and anxiety, with high scores indicating more symptoms. Besides measuring leptin levels in the blood, the researchers assessed the women's BMI, a measure of weight for height.The relationship between leptin and depression symptoms was independent of BMI. This finding indicates that leptin may mediate symptoms of depression and that this effect is not a function of low weight, Lawson said."Further research administering leptin to humans will be important in understanding whether this hormone has a potential role in the treatment of depression," she said.

WASHINGTON, June 23 (Xinhua) -- NASA's next Mars rover has completed the journey from its California birthplace to Florida in preparation for launch this fall, the U.S. space agency said Thursday in a statement.The Mars Science Laboratory (MSL) rover, also known as Curiosity, arrived Wednesday at NASA's Kennedy Space Center aboard an Air Force C-17 transport plane. It was accompanied by the rocket-powered descent stage that will fly the rover during the final moments before landing on Mars.The rover's aeroshell -- the protective covering for the trip to the Red Planet -- and the cruise stage, which will guide it to Mars, arrived at Kennedy last month. The mission is targeted to launch from Cape Canaveral Air Force Station between Nov. 25 and Dec. 18. The car-size rover will land on Mars in August 2012.The rover and other spacecraft components will undergo more testing before mission staff stack them and fuel the onboard propulsion systems. Curiosity should be enclosed in its aeroshell for the final time in September and delivered to Kennedy's Launch Complex 41 in early November for integration with a United Launch Alliance Atlas V rocket.Curiosity is about twice as long and more than five times as heavy as any previous Mars rover. Its 10 science instruments include two for ingesting and analyzing samples of powdered rock delivered by the rover's robotic arm. During a prime mission lasting one Martian year -- nearly two Earth years -- researchers will use the rover's tools to study whether the landing region has had environmental conditions favorable for supporting microbial life and favorable for preserving clues about whether life existed.

LOS ANGELES, June 5 (Xinhua) -- A latest study has found no evidence that screening for ovarian cancer may reduce the risk of dying from the disease, it was reported on Sunday.Screening, however, does increase the likelihood of unnecessary invasive procedures, according to researchers at the University of Utah.The researchers presented their findings at an on-going meeting of the American Society of Clinical Oncology in Chicago, The Los Angeles Times said.Researchers studied 78,216 women, ages 55 to 74, who participated in the National Cancer Institute's Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Half of the women received the usual care from their OB-gyns, and half received a CA 125 screening every year for six years and an ultrasound every year for four years. They were then followed for a maximum of 12 years.The researchers observed 212 ovarian cancers in the screened group and 176 in the normal care group. There were 118 ovarian cancer deaths in the screened group and 100 in the normal care group. The differences were not statistically significant. Overall, there were 2,924 deaths from all causes in the screened group and 2,914 in the normal care group.But the researchers also observed that 3,285 women had false- positive diagnoses from the screening. Among those, 1,080 underwent surgery that included an oophorectomy (surgical removal of one or both ovaries). Fifteen percent of those who had surgery developed major complications as a result. Overall, 1,771 women in the screened group (7.7 percent) had an oophorectomy, compared with 1,304 in the normal care group (5.8 percent)."We conclude that annual screening for ovarian cancer ... does not reduce disease-specific mortality in women at average risk for ovarian cancer but does increase invasive medical procedures and associated harms," the researchers said in the study.New data presented at the meeting also showed that the widely used cancer drug Avastin can improve treatment of ovarian cancer, The Times said.About 21,880 American women are diagnosed with ovarian cancer each year and about 13,850 die from it, according to the American Cancer Society. Because it produces few symptoms, the disease is typically not diagnosed until it has become advanced and spread throughout the body. As a result, five-year survival is only about 30 percent, and the disease is one of the five most deadly cancers among women. Being able to detect the cancer at an earlier stage when it might be more curable could thus, theoretically, improve the survival rate.The tests most commonly used to detect ovarian cancer include a transvaginal ultrasound to look for tumor masses and a blood test that screens for increased levels of a tumor marker called CA 125.

BEIJING, Sept. 26 (Xinhuanet) -- Weather forecasts showed that Thursday or Friday might be suitable for launching the Tiangong-1 spacecraft, experts said.The unmanned spacecraft, part of China's first spacecraft rendezvous and docking mission, was set to blast off from the Jiuquan Satellite Launch Center in Northwest China at an appropriate time between Tuesday and Friday.But the latest weather forecast showed that Tuesday and Wednesday would not be suitable for a launch, Cui Jijun, chief commander of the mission's launch site system, was quoted by China National Radio as saying on Sunday.A precondition for launching is that the average wind speed at the launch site should not be faster than 10 meters a second. The upper-level wind, at 300 meters to 25,000 meters above the Earth, should be no faster than 70 meters a second.The 8.5-ton Tiangong-1 spacecraft and the Long March II-F rocket stand at the Jiuquan Satellite Launch Center on Sept 20. The spacecraft is set to blast off at an appropriate time between Tuesday and Friday.If the wind is too strong, the rising rocket carrier could wiggle and pose a danger, experts said."Everything is ready now except for the right weather," Cui said.On Sunday afternoon, all systems of the Tiangong-1 project went through a joint maneuver, he said. Before that, the 8.5-ton spacecraft, and the Long March II-F rocket that will carry it skyward, were positioned onto the launch pad last Tuesday.Engineers carried out checkups on the conditions of the rocket and the spacecraft, among many other tests in the past few days. All preparation work is done except for fuel loading, he said.Wang Xiaoqing, a publicity official at the launch site, said that the fuel loading usually begins one day before the launch. Once the fuel is loaded into the carrier vehicle, the launch becomes "irreversible".Tiangong-1, or Heavenly Palace 1, will serve as "a target spacecraft" for three rendezvous and docking experiments.The spacecraft rendezvous and docking missions are expected to pave the way for the building of a planned space station scheduled for 2020, previous reports said.Following Tiangong-1, an unmanned Shenzhou VIII spaceship will blast off from the Jiuquan Satellite Launch Center later this year.Lu Jinrong, chief engineer of the mission's launch site system, said that it is rare that two launches of China's manned space program are scheduled in half a year."In the past, the launch site carried out one launch a year, or even one every two to three years," he said."We are already in a high-frequency launch period."

来源：资阳报